Annals of Thoracic Medicine Official publication of the Saudi Thoracic Society, affiliated to King Saud University
Search Ahead of print Current Issue Archives Instructions Subscribe e-Alerts Login 
Home Email this article link Print this article Bookmark this page Decrease font size Default font size Increase font size

    Article Cited by others


Clinical characteristics, comorbidities, and outcomes in patients with idiopathic pulmonary fibrosis

Alhamad Esam H, Cal Joseph G, Alrajhi Nuha N, Aharbi Waleed M, AlRikabi Ammar C, AlBoukai Ahmad A

Year : 2020| Volume: 15| Issue : 4 | Page no: 208-214

   This article has been cited by
1 Antifibrotics and Reduced Mortality in Idiopathic Pulmonary Fibrosis: Immortal Time Bias
Samy Suissa, Karine Suissa
American Journal of Respiratory and Critical Care Medicine. 2023; 207(1): 105
[Pubmed]  [Google Scholar] [DOI]
2 A Systematic Review of the Prognostic Significance of the Body Mass Index in Idiopathic Pulmonary Fibrosis
Angelo Zinellu, Ciriaco Carru, Pietro Pirina, Alessandro G. Fois, Arduino A. Mangoni
Journal of Clinical Medicine. 2023; 12(2): 498
[Pubmed]  [Google Scholar] [DOI]
3 Nintedanib and pirfenidone for idiopathic pulmonary fibrosis in King Abdulaziz Medical City, Riyadh: Real-life data
MohammedAyaz Khan, Nahed Sherbini, Sami Alyami, Abdullah Al-Harbi, Majed Al-Ghamdi, Suliman Alrajhi, Rajkumar Rajendram, Hamdan Al-Jahdali
Annals of Thoracic Medicine. 2023; 18(1): 45
[Pubmed]  [Google Scholar] [DOI]
4 The relative contribution of co-morbidities to health-related quality of life of people with idiopathic pulmonary fibrosis using the Assessment of Quality of Life-8-Dimension multi-attribute utility instrument
Qiang Zheng, Ingrid A. Cox, Barbara de Graaff, Julie A. Campbell, Tamera J. Corte, Ian Glaspole, Vidya Navaratnam, Peter Hopkins, Chris Zappala, Hasnat Ahmad, Ting Zhao, Sacha Macansh, E. Haydn Walters, Andrew J. Palmer
Quality of Life Research. 2022;
[Pubmed]  [Google Scholar] [DOI]
5 Real-World Clinical Outcomes Based on Body Mass Index and Annualized Weight Change in Patients with Idiopathic Pulmonary Fibrosis
Joyce S. Lee, Adam Martin-Schwarze, Elizabeth Freiheit, Ben Trzaskoma, Cindy Burg
Advances in Therapy. 2022;
[Pubmed]  [Google Scholar] [DOI]
6 Physical activity, exercise capacity and mortality risk in people with interstitial lung disease: a systematic review and meta-analysis
Vânia Rocha, Cátia Paixão, Alda Marques
Journal of Science and Medicine in Sport. 2022;
[Pubmed]  [Google Scholar] [DOI]
7 Investigation of clinical predictors of survival in idiopathic pulmonary fibrosis patients: A cohort study in Taiwan
Ching-Min Tseng, Mei-Yin Chen, Chen-Yu Kao, Chi-Wei Tao
Journal of the Chinese Medical Association. 2022; 85(5): 578
[Pubmed]  [Google Scholar] [DOI]
8 Idiopathic pulmonary fibrosis: Current and future treatment
Daniel S. Glass, David Grossfeld, Heather A. Renna, Priya Agarwala, Peter Spiegler, Joshua DeLeon, Allison B. Reiss
The Clinical Respiratory Journal. 2022;
[Pubmed]  [Google Scholar] [DOI]
9 Effects of oxygen supplementation in autonomic nervous system function during exercise in patients with idiopathic pulmonary fibrosis and exertional desaturation
Afroditi K. Boutou, Konstantina Dipla, Marieta P. Theodorakopoulou, Katerina Markopoulou, Georgia Pitsiou, Stavros Papadopoulos, Stella Kritikou, Ioannis Stanopoulos, Andreas Zafeiridis
The Clinical Respiratory Journal. 2021; 15(10): 1088
[Pubmed]  [Google Scholar] [DOI]
10 Impact of Antifibrotic Therapy on Mortality and Acute Exacerbation in Idiopathic Pulmonary Fibrosis
Tananchai Petnak, Ploypin Lertjitbanjong, Charat Thongprayoon, Teng Moua
Chest. 2021; 160(5): 1751
[Pubmed]  [Google Scholar] [DOI]
11 Clinical characteristics and outcomes in patients with primary Sjogren's syndrome-associated interstitial lung disease
EsamH Alhamad, JosephG Cal, NuhaN Alrajhi, MuthurajanP Paramasivam, WaleedM Alharbi, Mohammed AlEssa, MohammedA Omair, AmmarC AlRikabi, AhmadA AlBoukai
Annals of Thoracic Medicine. 2021; 16(2): 156
[Pubmed]  [Google Scholar] [DOI]


Read this article